American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Over the last 12 months, insiders at American Oncology Network, Inc. have bought $20,712 and sold $0 worth of American Oncology Network, Inc. stock.
On average, over the past 5 years, insiders at American Oncology Network, Inc. have bought $20,712 and sold $2.16M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Divers Stephen (Chief Medical Officer) — $10,750. Schonherz Todd (Chief Executive Officer) — $9,962.
The last purchase of 5,000 shares for transaction amount of $10,750 was made by Divers Stephen (Chief Medical Officer) on 2024‑05‑24.
2024-05-24 | Chief Medical Officer | 5,000 0.0059% | $2.15 | $10,750 | +58.69% | |||
2024-05-21 | Chief Executive Officer | 5,340 0.0055% | $1.87 | $9,962 | +95.59% | |||
2023-09-25 | Sale | 10 percent owner | 205,512 1.1821% | $10.50 | $2.16M | -69.69% |